SCHEMBL15860269

SCHEMBL15860269

Clc1nc(-c2ccc3ccccc3c2)c2cccnc2n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2B P41595 1/20 0.44
HTR5A P47898 1/20 0.44
CYP17A1 P05093 1/20 0.41
CYP19A1 P11511 1/20 0.41
CYP11B1 P15538 1/20 0.41
CYP11B2 P19099 1/20 0.41
ALDH1A1 P00352 4/20 0.40
KDM4E B2RXH2 3/20 0.40
MAPK9 P45984 2/20 0.40
MAPK10 P53779 2/20 0.40
MAPK8 P45983 1/20 0.40
NPC1 O15118 1/20 0.38
POLB P06746 1/20 0.38
RAB9A P51151 1/20 0.38
DHODH Q02127 1/20 0.37
CCR1 P32246 1/20 0.37
CCR8 P51685 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
LMNA P02545 2/20 0.37
MAPT P10636 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15860220 0.83 DHODH (0.52) ALDH1A1KDM4EDHODHL3MBTL1LMNA
SCHEMBL4146794 0.83 KDM4E (0.52) ALDH1A1KDM4EDHODHL3MBTL1LMNA
SCHEMBL17508360 0.82 ABCG2 (0.44) ALDH1A1KDM4EDHODHL3MBTL1LMNA
SCHEMBL15003551 0.82 HTR2B (0.47) HTR2BHTR5ACYP17A1CYP19A1CYP11B1
SCHEMBL17508361 0.81 MAPK9 (0.41) HTR2BHTR5ACYP17A1CYP19A1CYP11B1
SCHEMBL16218738 0.79 MAPK9 (0.48) HTR2BHTR5ACYP17A1CYP19A1CYP11B1
SCHEMBL15860223 0.78 KDM4E (0.64) HTR2BHTR5AALDH1A1KDM4EMAPK9
SCHEMBL29432929 0.78 KDM4E (0.64) HTR2BHTR5AALDH1A1KDM4EMAPK9
SCHEMBL16218744 0.78 ABCG2 (0.42) HTR2BHTR5ACYP11B1CYP11B2ALDH1A1
SCHEMBL17508370 0.78 CYP11B1 (0.43) CYP11B1ALDH1A1KDM4ECCR1CCR8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10763443-B2 Compound for organic electronic element, organic electronic element using the same, and electronic device thereof DUK SAN NEOLUX CO., LTD (KR) 2020-09-01 US disclosed
US-10672992-B2 Compound for organic electronic element, organic electronic element using the same, and electronic device thereof DUK SAN NEOLUX CO., LTD (KR) 2020-06-02 US disclosed
US-10446762-B2 Compound for organic electronic element, organic electronic element using the same, and electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2019-10-15 US disclosed
US-20190173023-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2019-06-06 US disclosed
US-20180083204-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2018-03-22 US disclosed
US-20180083204-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2018-03-22 US disclosed
US-9676767-B2 Indoloacridine-containing derivative, preparation process and use thereof, and organic luminescent device BOE TECHNOLOGY GROUP CO., LTD. (CN) 2017-06-13 US disclosed
US-9676767-B2 Indoloacridine-containing derivative, preparation process and use thereof, and organic luminescent device BOE TECHNOLOGY GROUP CO., LTD. (CN) 2017-06-13 US disclosed
US-9676767-B2 Indoloacridine-containing derivative, preparation process and use thereof, and organic luminescent device BOE TECHNOLOGY GROUP CO., LTD. (CN) 2017-06-13 US disclosed
US-20160046621-A1 INDOLOACRIDINE-CONTAINING DERIVATIVE, PREPARATION PROCESS AND USE THEREOF, AND ORGANIC LUMINESCENT DEVICE BOE TECHNOLOGY GROUP CO., LTD. (CN) 2016-02-18 US disclosed
US-20160046621-A1 INDOLOACRIDINE-CONTAINING DERIVATIVE, PREPARATION PROCESS AND USE THEREOF, AND ORGANIC LUMINESCENT DEVICE BOE TECHNOLOGY GROUP CO., LTD. (CN) 2016-02-18 US disclosed
US-20160046621-A1 INDOLOACRIDINE-CONTAINING DERIVATIVE, PREPARATION PROCESS AND USE THEREOF, AND ORGANIC LUMINESCENT DEVICE BOE TECHNOLOGY GROUP CO., LTD. (CN) 2016-02-18 US disclosed
US-20160005981-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2016-01-07 US disclosed
US-20160005981-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2016-01-07 US disclosed
WO-2014104585-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF 덕산하이메탈(주) (KR) 2014-07-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160046621-A1 INDOLOACRIDINE-CONTAINING DERIVATIVE, PREPARATION PROCESS AND USE THEREOF, AND ORGANIC LUMINESCENT DEVICE AHR, CDYL, SLC18A1 HTR2B 187/4885HTR5A 41/4885CYP17A1 3201/4885
US-20190173023-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND ELECTRONIC DEVICE THEREOF NFE2L2, OR51E2, ESR1 HTR2B 4621/4885HTR5A 4744/4885CYP17A1 954/4885
US-10763443-B2 Compound for organic electronic element, organic electronic element using the same, and electronic device thereof NFE2L2, OR51E2, ESR1 HTR2B 4621/4885HTR5A 4744/4885CYP17A1 954/4885
US-20180083204-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND ELECTRONIC DEVICE THEREOF NFE2L2, OR51E2, ESR1 HTR2B 4621/4885HTR5A 4744/4885CYP17A1 954/4885
US-10672992-B2 Compound for organic electronic element, organic electronic element using the same, and electronic device thereof NFE2L2, OR51E2, ESR1 HTR2B 4621/4885HTR5A 4744/4885CYP17A1 954/4885
US-20160005981-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND ELECTRONIC DEVICE THEREOF NFE2L2, OR51E2, ESR1 HTR2B 4621/4885HTR5A 4744/4885CYP17A1 954/4885
US-10446762-B2 Compound for organic electronic element, organic electronic element using the same, and electronic device thereof NFE2L2, OR51E2, ESR1 HTR2B 4621/4885HTR5A 4744/4885CYP17A1 954/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.